-

AM Best to Host Briefing on Rating Insurance-Related Asset-Backed Securities

OLDWICK, N.J.--(BUSINESS WIRE)--Senior analysts from AM Best will review the rating of insurance-related asset-backed securities (ABS) transactions in an online briefing scheduled for Thursday, Jan. 9, 2025, at 11 a.m. (EST).

Due to the unique nature of this insurance asset class, the rating of insurance-related ABS transactions can require further clarification of our process. Emmanuel Modu, managing director, and Wai Tang, senior director, both in AM Best’s Global Reinsurance & ILS department, will lead the briefing, titled “The Rating of Insurance-Related Asset-Backed Securities, Questions Answered,” during which they will explore common types of insurance ABS transactions and the key assumptions behind their ratings.

The analysts also will discuss the default rates applied to the transactions’ collateral; the asset-dependent recovery rates; the use of credit substitution and enhancement on collateral and rated securities; and the determination of the implied rating of the securities by applying Best’s Idealized Issue Default Matrix.

To register for the complimentary briefing, please go to https://web.ambest.com/about/events/briefings/asset-backed-securities.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

Industry:

AM Best

Release Versions
English
Hashtags
#insurance

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 908 882 2310
christopher.sharkey@ambest.com

Al Slavin
Senior Public Relations Specialist
+1 908 882 2318
al.slavin@ambest.com

Social Media Profiles
AM Best / LinkedIn
More News From AM Best

AM Best Assigns Credit Ratings to Charp Re, Ltd.

MEXICO CITY--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating of B++ (Good) and a Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) to Charp Re, Ltd. (Charp Re) (Turks & Caicos Islands). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect Charp Re’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ER...

AM Best Revises Outlooks to Positive for FMH Insurance Group’s Members

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Farmers Mutual Hail Insurance Company of Iowa and its reinsured affiliate, FMH Ag Risk Insurance Company. Both companies are domiciled in West Des Moines, IA and are collectively referred to as FMH Insurance Group (FMH).The Credit Ratings (ratings) reflect FMH’s overall balance sheet str...

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...
Back to Newsroom